Intratumoral chemotherapy with cisplatin in oily emulsion in horses

Alain P. Théon From the Departments of Radiological Sciences (Théon), Surgery (Pascoe), and Medicine (Carlson), School of Veterinary Medicine, and the Department of Surgery (Krag), School of Medicine, University of California, Davis, CA 95616.

Search for other papers by Alain P. Théon in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
John R. Pascoe From the Departments of Radiological Sciences (Théon), Surgery (Pascoe), and Medicine (Carlson), School of Veterinary Medicine, and the Department of Surgery (Krag), School of Medicine, University of California, Davis, CA 95616.

Search for other papers by John R. Pascoe in
Current site
Google Scholar
PubMed
Close
 BVSc, PhD
,
Gary P. Carlson From the Departments of Radiological Sciences (Théon), Surgery (Pascoe), and Medicine (Carlson), School of Veterinary Medicine, and the Department of Surgery (Krag), School of Medicine, University of California, Davis, CA 95616.

Search for other papers by Gary P. Carlson in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
David N. Krag From the Departments of Radiological Sciences (Théon), Surgery (Pascoe), and Medicine (Carlson), School of Veterinary Medicine, and the Department of Surgery (Krag), School of Medicine, University of California, Davis, CA 95616.

Search for other papers by David N. Krag in
Current site
Google Scholar
PubMed
Close
 MD

Click on author name to view affiliation information

Summary:

Twenty horses with 30 lesions were studied to evaluate the effects of intratumoral chemotherapy with cisplatin in sesame oil on equine sarcoids (n = 19), squamous cell carcinomas (n = 7), and squamous cell papillomas (n = 4). Treatment consisted of 4 sessions of intratumoral cisplatin chemotherapy at 2-week intervals. A controlled-release formulation of cisplatin in sesame oil was used to limit drug egress from the injection site. Mean dosage per session was 0.97 (±0.17, sem) mg of cisplatin/cm3 of tumor tissue treated for tumor volumes ranging from 10 to 20 cm3. Dosage tended to be slightly higher for smaller tumors and slightly lower for larger tumors. Tumor regression was observed in all horses. Complete response was observed in 18 of the sarcoids, 5 of the squamous cell carcinomas, and 4 of the squamous cell papillomas. The mean relapse-free interval was 21.6 and 14 months in horses with sarcoid and carcinoma/papilloma, respectively. The 1-year relapse-free rates were 87 and 65% for equine sarcoid and carcinoma/papilloma, respectively. In horses with relapse, 70% had tumor recurrence outside the treated field. Cisplatin-related local toxicosis was minimal. Intratumoral cisplatin chemotherapy was found to be a practical and effective treatment of sarcoid and squamous cell carcinoma/papilloma in horses.

Summary:

Twenty horses with 30 lesions were studied to evaluate the effects of intratumoral chemotherapy with cisplatin in sesame oil on equine sarcoids (n = 19), squamous cell carcinomas (n = 7), and squamous cell papillomas (n = 4). Treatment consisted of 4 sessions of intratumoral cisplatin chemotherapy at 2-week intervals. A controlled-release formulation of cisplatin in sesame oil was used to limit drug egress from the injection site. Mean dosage per session was 0.97 (±0.17, sem) mg of cisplatin/cm3 of tumor tissue treated for tumor volumes ranging from 10 to 20 cm3. Dosage tended to be slightly higher for smaller tumors and slightly lower for larger tumors. Tumor regression was observed in all horses. Complete response was observed in 18 of the sarcoids, 5 of the squamous cell carcinomas, and 4 of the squamous cell papillomas. The mean relapse-free interval was 21.6 and 14 months in horses with sarcoid and carcinoma/papilloma, respectively. The 1-year relapse-free rates were 87 and 65% for equine sarcoid and carcinoma/papilloma, respectively. In horses with relapse, 70% had tumor recurrence outside the treated field. Cisplatin-related local toxicosis was minimal. Intratumoral cisplatin chemotherapy was found to be a practical and effective treatment of sarcoid and squamous cell carcinoma/papilloma in horses.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 299 299 140
PDF Downloads 108 108 44
Advertisement